{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:06:41Z","timestamp":1770822401929,"version":"3.50.1"},"reference-count":69,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2002,4,25]],"date-time":"2002-04-25T00:00:00Z","timestamp":1019692800000},"content-version":"vor","delay-in-days":510,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Patients who are refractory to platelet transfusion as a result of HLA alloimmunization are generally given HLA\u2010matched or crossmatched platelets. However, HLA\u2010matched platelets that are matched at HLA\u2010A and \u2010B loci (A\u2010matched) or those without any mismatched or cross\u2010reactive antigens (BU\u2010matched) are frequently unavailable. A disadvantage of crossmatching is that crossmatched platelets have a shelf life of only 5 days, so that crossmatch tests must be performed frequently for patients requiring long\u2010term platelet transfusions. An alternative method is the selection of platelets according to the patient's HLA antibody specificity, called the antibody specificity prediction (ASP) method.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> An anti\u2010human globulin\u2010enhanced microlymphocytotoxicity test modified by a double addition of serum and a computer program were used to determine the specificity of patients' HLA antibodies. Platelet crossmatching was performed with a solid\u2010phase adherence assay. The percentage of platelet recovery (PPR) was determined in 1621 platelet transfusions in an observational study in 114 patients, and the PPR of platelets selected by the ASP method was compared with the PPR of those that were HLA\u2010matched, crossmatched, or randomly selected. The numbers of potential donors in files of HLA\u2010typed donors as identified by HLA matching vs. the ASP method were determined.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> After adjustments for covariates, the mean \u00b1 SEM PPR was similar for HLA\u2010matched (21 \u00b1 4%), cross\u2010matched (23 \u00b1 4%), and ASP\u2010selected (24 \u00b1 3%) platelets and was significantly lower for randomly selected (15 \u00b1 1.4%) platelets. For 29 alloimmunized HLA\u2010typed patients, the mean number of potential donors found in a file of 7247 HLA\u2010typed donors was 6 who were an HLA\u2010A match (median = 1), 33 who were an HLA\u2010BU match (median = 20), and 1426 who were identified by the ASP method (median = 1365).<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> The ASP method of donor selection for refractory alloimmunized patients appears as effective as HLA matching or crossmatching. Far more donors are identified in a file of HLA\u2010typed donors by the ASP method than by HLA matching, and this indicates that the ASP method provides important advantages regarding the availability of compatible platelet components.<\/jats:p>","DOI":"10.1046\/j.1537-2995.2000.40121446.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:42:03Z","timestamp":1047508923000},"page":"1446-1456","source":"Crossref","is-referenced-by-count":98,"title":["Selecting donors of platelets for refractory patientson the basis of HLA antibody specificity"],"prefix":"10.1111","volume":"40","author":[{"given":"Lawrence D.","family":"Petz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Garratty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loni","family":"Calhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill D.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul I.","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Gresens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Gornbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot M.","family":"Landaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Cecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,25]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"359","volume-title":"Clinical practice of transfusion medicine","author":"Petz LD","year":"1996"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.21307\/immunohematology-2019-675","article-title":"Selecting platelets for transfusion of the alloimmunized patient: a review.","volume":"14","author":"Murphy S","year":"1998","journal-title":"Immunohematology"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V71.2.383.383","article-title":"Clinical factors influencing the efficacy of pooled platelet transfusions.","volume":"71","author":"Bishop JF","year":"1988","journal-title":"Blood"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood.V81.12.3428.3428","article-title":"Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization.","volume":"81","author":"Friedberg RC","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_6_2","first-page":"1035","article-title":"Factors associated with response to platelet transfusion following hematopoietic stem cell transplantion.","volume":"17","author":"Klumpp TR","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1994.tb00310.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.447982.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1996.36111297091736.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1991.31591263191.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07757.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb03262.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830140407"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35895357895.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.1980.03300310023016","article-title":"Platelet transfusion therapy. One\u2010hour posttransfusion increments are valuable in predicting the need for HLA\u2010matched preparations.","volume":"243","author":"Daly PA","year":"1980","journal-title":"JAMA"},{"key":"e_1_2_5_16_2","first-page":"315","article-title":"Alloimmunization and platelet transfusion.","volume":"33","author":"McFarland JG","year":"1996","journal-title":"Semin Hematol"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32993110756.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7610001.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3148.1992.tb00175.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1992.32792391036.x"},{"key":"e_1_2_5_21_2","first-page":"91","article-title":"Management of patients refractory to platelet transfusion\u2014an evaluation of methods of donor selection.","volume":"15","author":"Schiffer CA","year":"1987","journal-title":"Prog Hematol"},{"key":"e_1_2_5_22_2","first-page":"95","volume-title":"Transfusion medicine in the 1990's","author":"Slichter SJ","year":"1990"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(90)70269-6"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/90.1.63"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/90.1.114"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V61.2.238.238","article-title":"A radiolabeled antiglobulin test for crossmatching platelet transfusions.","volume":"61","author":"Kickler TS","year":"1983","journal-title":"Blood"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29489242795.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1983.23483276859.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1987.27587320531.x"},{"issue":"1","key":"e_1_2_5_30_2","first-page":"546a","article-title":"The effectiveness of an antibody specificity prediction (ASP) method for selecting platelets for transfusion to alloimmunized patients (abstract).","volume":"86","author":"Petz LD","year":"1995","journal-title":"Blood"},{"key":"e_1_2_5_31_2","first-page":"44S","article-title":"Selecting platelet donors for refractory patients using HLA antibody specificity (abstract).","volume":"39","author":"Petz LD","year":"1999","journal-title":"Transfusion"},{"key":"e_1_2_5_32_2","first-page":"133","volume-title":"The HLA system: basic biology and clinical applications","author":"Petz LD","year":"1999"},{"key":"e_1_2_5_33_2","first-page":"198","article-title":"Platelet transfusion therapy for the cancer patient.","volume":"17","author":"Heyman MR","year":"1990","journal-title":"Semin Oncol"},{"issue":"1","key":"e_1_2_5_34_2","first-page":"229a","article-title":"Preselection of platelet donors based on the identification of HLA antibodies in multiply transfused hematology patients (abstract).","volume":"64","author":"Oldfather JW","year":"1984","journal-title":"Blood"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-4-332"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/204998b0"},{"key":"e_1_2_5_37_2","first-page":"33S","article-title":"The predictive value of three definitions of platelet transfusion refractoriness (abstract).","volume":"28","author":"Koerner TAW","year":"1988","journal-title":"Transfusion"},{"key":"e_1_2_5_38_2","first-page":"425","volume-title":"Williams hematology","author":"Erslev AJ","year":"1995"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33493242647.x"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.33493242647.x"},{"issue":"1","key":"e_1_2_5_41_2","first-page":"229a","article-title":"The use of the antiglobulin\u2010augmented lymphocytotoxic crossmatch in predicting the outcome of single\u2010donor platelet transfusions (abstract).","volume":"64","author":"Oldfather JW","year":"1984","journal-title":"Blood"},{"key":"e_1_2_5_42_2","first-page":"1212","article-title":"The occurrence of cross\u2010reactive \u201cpublic\u201d antibodies in the sera of highly sensitized dialysis patients.","volume":"15","author":"Oldfather J","year":"1983","journal-title":"Transplant Proc"},{"key":"e_1_2_5_43_2","first-page":"463","article-title":"Use of an antiglobulin\u2010ATG reagent for detection of low levels of alloanti\u2010body\u2014improvement of allograft survival in presensitized recipients.","volume":"10","author":"Fuller TC","year":"1978","journal-title":"Transplant Proc"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199509000-00016"},{"key":"e_1_2_5_45_2","first-page":"435","volume-title":"Clinical transplants","author":"Clark BD","year":"1992"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.220.4598.671"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb02344.x"},{"key":"e_1_2_5_48_2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood.V70.6.1727.1727","article-title":"Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients.","volume":"70","author":"Lee EJ","year":"1987","journal-title":"Blood"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1988.tb04212.x"},{"key":"e_1_2_5_50_2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/blood.V81.2.538.538","article-title":"Downregulation of the anti\u2010HLA alloimmune response by variable region\u2010reactive (anti\u2010idiotypic) antibodies in leukemic patients transfused with platelet concentrates.","volume":"81","author":"Atlas E","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1989.tb00818.x"},{"key":"e_1_2_5_52_2","volume-title":"Technical Manual","author":"Vengelen\u2010Tyler V","year":"1999"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39060586.x"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35195090653.x"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0198-8859(94)90270-4"},{"key":"e_1_2_5_56_2","first-page":"519","article-title":"Donor availability for platelet transfusion support of alloimmunized thrombocytopenic patients.","volume":"9","author":"Duquesnoy RJ","year":"1977","journal-title":"Transplant Proc"},{"key":"e_1_2_5_57_2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood.V50.3.407.407","article-title":"Influence of HLA\u2010A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients.","volume":"50","author":"Duquesnoy RJ","year":"1977","journal-title":"Blood"},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1984.24484275567.x"},{"key":"e_1_2_5_59_2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.V59.5.971.971","article-title":"Effect of HLA Bw4\/Bw6 compatibility on platelet transfusion responses of refractory thrombocytopenic patients.","volume":"59","author":"McElligott MC","year":"1982","journal-title":"Blood"},{"key":"e_1_2_5_60_2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood.V74.3.1172.1172","article-title":"Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets.","volume":"74","author":"Schiffer CA","year":"1989","journal-title":"Blood"},{"key":"e_1_2_5_61_2","first-page":"38","article-title":"Alloimmunization to public HLA antigens in multi\u2010transfused platelet recipients.","volume":"16","author":"MacPherson BR","year":"1986","journal-title":"Ann Clin Lab Sci"},{"key":"e_1_2_5_62_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V70.1.23.23","article-title":"An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.","volume":"70","author":"Heal JM","year":"1987","journal-title":"Blood"},{"key":"e_1_2_5_63_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood.V42.3.405.405","article-title":"Immunologic response of patients with acute leukemia to platelet transfusions.","volume":"42","author":"Tejada F","year":"1973","journal-title":"Blood"},{"key":"e_1_2_5_64_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1978.18478251250.x"},{"key":"e_1_2_5_65_2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1182\/blood.V58.1.122.122","article-title":"Suppression of transfusion\u2010related alloimmunization in intensively treated cancer patients.","volume":"58","author":"Holohan TV","year":"1981","journal-title":"Blood"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1936.x"},{"issue":"1","key":"e_1_2_5_67_2","first-page":"218a","article-title":"Frequency of alloimmunization to platelet\u2010specific antigens in multitransfused thrombocytopenic patients (abstract).","volume":"8","author":"O'Neill GJ","year":"1992","journal-title":"Blood"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1996.d01-58.x"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1996.tb01937.x"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39070772.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2000.40121446.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2000.40121446.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T15:27:47Z","timestamp":1698593267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2000.40121446.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["10.1046\/j.1537-2995.2000.40121446.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2000.40121446.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}